Orthopediatrics (KIDS) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$252.7M

Revenue (quarter)

$70.5M

Revenue growth (year over year)

+15.43%

Gross profit (trailing twelve months)

$186.1M

Gross margin

73.65%

Net income (trailing twelve months)

−$39.7M

Net income (quarter)

−$7.2M

Net income growth (year over year)

−0.70%

Net margin

−15.72%

Return on equity

−11.36%

EPS (trailing twelve months)

−$1.68

Book value per share

$13.16

P/E (trailing twelve months)

—

Price to book

1.68

Debt to assets

32.81%

Payout ratio

—

Dividend yield

—

Company profile

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.

• Is Orthopediatrics (KIDS) profitable?

  No. Orthopediatrics reported a net loss of $39.7M over the trailing twelve months.

• How much revenue does Orthopediatrics (KIDS) make?

  Orthopediatrics generated $252.7M in revenue over the trailing twelve months, up 15.43% year over year.

• How do I buy stock in Orthopediatrics (KIDS)?

  KIDS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.